Lin YC - Search Results

1

Human p16gamma, a novel transcriptional variant of p16(INK4A), coexpresses with p16(INK4A) in cancer cells and inhibits cell-cycle progression.

Lin YC, Diccianni MB, Kim Y, Lin HH, Lee CH, Lin RJ, Joo SH, Li J, Chuang TJ, Yang AS, Kuo HH, Tsai MD, Yu AL. Lin YC, et al. Among authors: lin rj, lin hh. Oncogene. 2007 Oct 25;26(49):7017-27. doi: 10.1038/sj.onc.1210507. Epub 2007 May 7. Oncogene. 2007. PMID: 17486064

2

Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen.

Wang Q, Li DC, Li ZF, Liu CX, Xiao YM, Zhang B, Li XD, Zhao J, Chen LP, Xing XM, Tang SF, Lin YC, Lai YD, Yang P, Zeng JL, Xiao Q, Zeng XW, Lin ZN, Zhuang ZX, Zhuang SM, Chen W. Wang Q, et al. Among authors: lin zn, lin yc. Oncogene. 2011 Sep 8;30(36):3875-86. doi: 10.1038/onc.2011.103. Epub 2011 Apr 4. Oncogene. 2011. PMID: 21460851

3

α4 is highly expressed in carcinogen-transformed human cells and primary human cancers.

Chen LP, Lai YD, Li DC, Zhu XN, Yang P, Li WX, Zhu W, Zhao J, Li XD, Xiao YM, Zhang Y, Xing XM, Wang Q, Zhang B, Lin YC, Zeng JL, Zhang SX, Liu CX, Li ZF, Zeng XW, Lin ZN, Zhuang ZX, Chen W. Chen LP, et al. Among authors: lin zn, lin yc. Oncogene. 2011 Jun 30;30(26):2943-53. doi: 10.1038/onc.2011.20. Epub 2011 Feb 21. Oncogene. 2011. PMID: 21339737

4

Efficacy of albendazole combined with a marine fungal extract (m2-9) against Angiostrongylus cantonensis-induced meningitis in mice.

Li ZY, Sun R, Li J, Song YX, Lin YC, Zeng X, He HJ, Wei J, Yang F, Zheng HQ, Lv ZY, Wu ZD. Li ZY, et al. Among authors: lin yc. J Helminthol. 2012 Dec;86(4):410-7. doi: 10.1017/S0022149X11000630. Epub 2011 Nov 4. J Helminthol. 2012. PMID: 22050968

5

Downscaling of Non-Van der Waals Semimetallic W₅N₆ with Resistivity Preservation.

Gao H, Zhou D, Ping L, Wang Z, Hung NT, Cao J, Geiwitz M, Natale G, Lin YC, Burch KS, Saito R, Terrones M, Ling X. Gao H, et al. Among authors: lin yc. ACS Nano. 2025 Jan 16. doi: 10.1021/acsnano.4c12155. Online ahead of print. ACS Nano. 2025. PMID: 39817314

6

Rethinking Repeat Two-Stage Knee Exchange Arthroplasty: Outcomes, Risks, and Decision-Making.

Huang YY, Hu CC, Lee SH, Chang CH, Lin SH, Lin YC. Huang YY, et al. Among authors: lin yc. J Arthroplasty. 2025 Jan 13:S0883-5403(25)00022-1. doi: 10.1016/j.arth.2025.01.007. Online ahead of print. J Arthroplasty. 2025. PMID: 39814115

7

Feasibility trial of STRONG: A digital intervention to improve nutritional management for individuals with esophageal and gastroesophageal junction cancer.

Lin YC, Pimiento JM, Milano J, Riccardi D, Mckinnie N, Hume E, Sprow O, Diaz-Carraway S, Budnetz M, Hagen R, Al-Jumayli M, Pereira AL, Sinnamon AJ, Somasundaram A, Permuth JB, Tabriz AA, Turner K. Lin YC, et al. Contemp Clin Trials Commun. 2024 Dec 23;43:101421. doi: 10.1016/j.conctc.2024.101421. eCollection 2025 Feb. Contemp Clin Trials Commun. 2024. PMID: 39810840 Free PMC article.

8

A Streamlined Approach to Anticounterfeiting Technologies: Patterned AAO Membranes Based on Photonic Crystal Effects with Tunable Color Shifts and pH Responsiveness.

Lin YC, Lee LR, Tsai TH, Lin J, Hsu YS, Kesavan M, Lin YL, Chen YF, Chen JT. Lin YC, et al. Small. 2025 Jan 14:e2409919. doi: 10.1002/smll.202409919. Online ahead of print. Small. 2025. PMID: 39807677

9

Plasma Hepatic Transaminases and Incidence of Metabolic Syndrome Before Midlife in Military Adults: A CHIEF Cohort Study.

Liu FC, Chen KW, Tsai KZ, Chu CC, Lin YC, Chang YC, Lin GM. Liu FC, et al. Among authors: lin yc. Endocr Metab Immune Disord Drug Targets. 2025 Jan 9. doi: 10.2174/0118715303326392241022050205. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2025. PMID: 39806968

10

Associations of Chronic Hepatitis B and Nonalcoholic Fatty Liver Diseases with New-Onset Metabolic Syndrome in Military Personnel before Midlife: A Cohort Study.

Tsai KZ, Liu PY, Lin YC, Huang CM, Wang HS, Lin GM. Tsai KZ, et al. Among authors: lin yc. Endocr Metab Immune Disord Drug Targets. 2025 Jan 9. doi: 10.2174/0118715303323078241022050619. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2025. PMID: 39806964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,536 results

Search Page

Filters